id: sud_medication_treatment_rate_oud_to_recidivism_rate_3_year
name: OUD Medication Treatment Rate (Extended Release Naltrexone) â†’ Recidivism Rate (3-Year)
from_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: OUD Medication Treatment Rate (Extended Release Naltrexone)
to_node:
  node_id: recidivism_rate_3_year
  node_name: Recidivism Rate (3-Year)
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Criminal justice-involved individuals with OUD receive extended-release naltrexone (XR-NTX)
  as medication for opioid use disorder'
- 'Step 2: XR-NTX reduces opioid use through opioid receptor antagonism but does not address underlying
  social determinants'
- 'Step 3: Structural factors including stigma, lack of employment, housing instability, and criminal
  record barriers persist despite medication treatment'
- 'Step 4: These unaddressed structural determinants continue to drive criminal justice involvement regardless
  of medication status'
- 'Step 5: No significant difference in arrest incidence between XR-NTX and treatment as usual groups'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: William E Soares et al. 2019. "Incidence of future arrests in adults involved in the
    criminal justice system with opioid use disorder receiving extended release naltrexone compared to
    treatment as usual.." https://doi.org/10.1016/j.drugalcdep.2018.10.035
  supporting_citations:
  - Additional citations require full-text access - this abstract references a 'published randomized trial'
    but does not provide specific citations
  - Study methodology suggests prior literature on MOUD and criminal justice outcomes
  - References to concerns regarding diversion and stigma limiting CJS treatment suggest prior policy
    literature
  doi: 10.1016/j.drugalcdep.2018.10.035
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: This randomized trial found no significant difference in arrest incidence between criminal
  justice-involved individuals with OUD who received extended-release naltrexone (47.6%) versus treatment
  as usual (42.5%). Despite XR-NTX's efficacy in reducing opioid use, it alone was insufficient to reduce
  criminal recidivism, highlighting that medication treatment without addressing structural determinants
  (employment, housing, stigma, criminal record barriers) does not reduce justice involvement.
quantitative_effects:
  effect_size:
    value: 1.38
    type: odds_ratio
    ci_lower: 0.85
    ci_upper: 2.22
  p_value: 0.37
  sample_size: 300
moderators:
- name: gender
  direction: strengthens
  strength: moderate
  description: Analysis controlled for gender as a potential confounder in the relationship
- name: age
  direction: strengthens
  strength: moderate
  description: Age was controlled for in multivariable models as a potential modifier
- name: previous_criminal_activity
  direction: strengthens
  strength: strong
  description: Prior criminal history controlled for as a key predictor of future arrests
- name: non_opioid_drug_use
  direction: strengthens
  strength: moderate
  description: Use of non-opioid drugs was controlled for, suggesting polysubstance use may independently
    predict recidivism
structural_competency:
  equity_implications: This study demonstrates that biomedical interventions alone (medication for OUD)
    are insufficient to address complex social outcomes like criminal recidivism. The finding that XR-NTX
    reduces opioid use but not arrests points to the critical role of structural determinants beyond substance
    use in driving criminal justice involvement. The paper notes that stigma and concerns about diversion
    limit treatment access in CJS populations, reflecting systemic barriers. Addressing recidivism requires
    comprehensive reentry support including housing, employment, and addressing the collateral consequences
    of criminal records - not just medication.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.577819'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
